Should Weakness in Rogers Corporation's (NYSE:ROG) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? — Oct 21st, 2024

Rogers (NYSE:ROG) has had a rough three months with its share price down 19%. However, the company's fundamentals look pretty decent, and long-term financials are usually aligned with future market price movements. Particularly, we will be paying attention to Rogers' ROE today. Return on...

Should Weakness in Rogers Corporation's (NYSE:ROG) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? — Oct 21st, 2024

Rogers (NYSE:ROG) has had a rough three months with its share price down 19%. However, the company's fundamentals look pretty decent, and long-term financials are usually aligned with future market price movements. Particularly, we will be paying attention to Rogers' ROE today. Return on...

Roche receives FDA approval for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY — Oct 18th, 2024

The new VENTANA CLDN18 (43-14A) RxDx Assay helps fulfil an unmet medical need by enabling clinicians to identify patients with gastric or gastroesophageal junction (GEJ) cancer who may benefit from a targeted treatment option. CLDN18.2 is an emerging biomarker in gastric and GEJ cancers a...

Rogers Corporation Schedules Third Quarter 2024 Earnings Call for October 24 — Oct 10th, 2024

CHANDLER, Ariz., October 10, 2024--(BUSINESS WIRE)--Rogers Corporation (NYSE:ROG) ("Rogers") plans to announce third quarter 2024 results on October, 24, 2024 after market close, which will be followed by a conference call at 5:00 pm ET. The call will be hosted by Colin Gouveia, President ...

Should Weakness in Rogers Corporation's (NYSE:ROG) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? — Oct 21st, 2024

Rogers (NYSE:ROG) has had a rough three months with its share price down 19%. However, the company's fundamentals look pretty decent, and long-term financials are usually aligned with future market price movements. Particularly, we will be paying attention to Rogers' ROE today. Return on...

Electronic Components Stocks Q2 Results: Benchmarking Allient (NASDAQ:ALNT) — Oct 7th, 2024

Electronic Components Stocks Q2 Results: Benchmarking Allient (NASDAQ:ALNT) The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Allient (NASDAQ:ALNT) and the rest of the...

Roche receives FDA approval for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY — Oct 18th, 2024

The new VENTANA CLDN18 (43-14A) RxDx Assay helps fulfil an unmet medical need by enabling clinicians to identify patients with gastric or gastroesophageal junction (GEJ) cancer who may benefit from a targeted treatment option. CLDN18.2 is an emerging biomarker in gastric and GEJ cancers a...

Should Weakness in Rogers Corporation's (NYSE:ROG) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? — Oct 21st, 2024

Rogers (NYSE:ROG) has had a rough three months with its share price down 19%. However, the company's fundamentals look pretty decent, and long-term financials are usually aligned with future market price movements. Particularly, we will be paying attention to Rogers' ROE today. Return on...

Electronic Components Stocks Q2 Results: Benchmarking Allient (NASDAQ:ALNT) — Oct 7th, 2024

Electronic Components Stocks Q2 Results: Benchmarking Allient (NASDAQ:ALNT) The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Allient (NASDAQ:ALNT) and the rest of the...

Should Weakness in Rogers Corporation's (NYSE:ROG) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? — Oct 21st, 2024

Rogers (NYSE:ROG) has had a rough three months with its share price down 19%. However, the company's fundamentals look pretty decent, and long-term financials are usually aligned with future market price movements. Particularly, we will be paying attention to Rogers' ROE today. Return on...

Electronic Components Stocks Q2 Results: Benchmarking Allient (NASDAQ:ALNT) — Oct 7th, 2024

Electronic Components Stocks Q2 Results: Benchmarking Allient (NASDAQ:ALNT) The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Allient (NASDAQ:ALNT) and the rest of the...

Should Weakness in Rogers Corporation's (NYSE:ROG) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? — Oct 21st, 2024

Rogers (NYSE:ROG) has had a rough three months with its share price down 19%. However, the company's fundamentals look pretty decent, and long-term financials are usually aligned with future market price movements. Particularly, we will be paying attention to Rogers' ROE today. Return on...

Survey commissioned by Roche shows that HPV infection, which causes 99% of all cervical cancer cases, remains largely misunderstood by the general public — Oct 8th, 2024

Survey findings from over 8,700 people in 12 countries show that half of those polled have inadequate understanding of HPV, with nearly one-third being unsure or unaware of it altogether.1 Findings also show that significant barriers continue to exist that are preventing women from seekin...

Should Weakness in Rogers Corporation's (NYSE:ROG) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? — Oct 21st, 2024

Rogers (NYSE:ROG) has had a rough three months with its share price down 19%. However, the company's fundamentals look pretty decent, and long-term financials are usually aligned with future market price movements. Particularly, we will be paying attention to Rogers' ROE today. Return on...

Rogers Corporation Schedules Third Quarter 2024 Earnings Call for October 24 — Oct 10th, 2024

CHANDLER, Ariz., October 10, 2024--(BUSINESS WIRE)--Rogers Corporation (NYSE:ROG) ("Rogers") plans to announce third quarter 2024 results on October, 24, 2024 after market close, which will be followed by a conference call at 5:00 pm ET. The call will be hosted by Colin Gouveia, President ...

Electronic Components Stocks Q2 Results: Benchmarking Allient (NASDAQ:ALNT) — Oct 7th, 2024

Electronic Components Stocks Q2 Results: Benchmarking Allient (NASDAQ:ALNT) The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Allient (NASDAQ:ALNT) and the rest of the...

Roche receives FDA approval for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY — Oct 18th, 2024

The new VENTANA CLDN18 (43-14A) RxDx Assay helps fulfil an unmet medical need by enabling clinicians to identify patients with gastric or gastroesophageal junction (GEJ) cancer who may benefit from a targeted treatment option. CLDN18.2 is an emerging biomarker in gastric and GEJ cancers a...

Roche receives FDA approval for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY — Oct 18th, 2024

The new VENTANA CLDN18 (43-14A) RxDx Assay helps fulfil an unmet medical need by enabling clinicians to identify patients with gastric or gastroesophageal junction (GEJ) cancer who may benefit from a targeted treatment option. CLDN18.2 is an emerging biomarker in gastric and GEJ cancers a...

Should Weakness in Rogers Corporation's (NYSE:ROG) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? — Oct 21st, 2024

Rogers (NYSE:ROG) has had a rough three months with its share price down 19%. However, the company's fundamentals look pretty decent, and long-term financials are usually aligned with future market price movements. Particularly, we will be paying attention to Rogers' ROE today. Return on...

Survey commissioned by Roche shows that HPV infection, which causes 99% of all cervical cancer cases, remains largely misunderstood by the general public — Oct 8th, 2024

Survey findings from over 8,700 people in 12 countries show that half of those polled have inadequate understanding of HPV, with nearly one-third being unsure or unaware of it altogether.1 Findings also show that significant barriers continue to exist that are preventing women from seekin...

Survey commissioned by Roche shows that HPV infection, which causes 99% of all cervical cancer cases, remains largely misunderstood by the general public — Oct 8th, 2024

Survey findings from over 8,700 people in 12 countries show that half of those polled have inadequate understanding of HPV, with nearly one-third being unsure or unaware of it altogether.1 Findings also show that significant barriers continue to exist that are preventing women from seekin...

Should Weakness in Rogers Corporation's (NYSE:ROG) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? — Oct 21st, 2024

Rogers (NYSE:ROG) has had a rough three months with its share price down 19%. However, the company's fundamentals look pretty decent, and long-term financials are usually aligned with future market price movements. Particularly, we will be paying attention to Rogers' ROE today. Return on...

Rogers Corporation Schedules Third Quarter 2024 Earnings Call for October 24 — Oct 10th, 2024

CHANDLER, Ariz., October 10, 2024--(BUSINESS WIRE)--Rogers Corporation (NYSE:ROG) ("Rogers") plans to announce third quarter 2024 results on October, 24, 2024 after market close, which will be followed by a conference call at 5:00 pm ET. The call will be hosted by Colin Gouveia, President ...

Rogers Corporation Schedules Third Quarter 2024 Earnings Call for October 24 — Oct 10th, 2024

CHANDLER, Ariz., October 10, 2024--(BUSINESS WIRE)--Rogers Corporation (NYSE:ROG) ("Rogers") plans to announce third quarter 2024 results on October, 24, 2024 after market close, which will be followed by a conference call at 5:00 pm ET. The call will be hosted by Colin Gouveia, President ...

Rogers Corporation Schedules Third Quarter 2024 Earnings Call for October 24 — Oct 10th, 2024

CHANDLER, Ariz., October 10, 2024--(BUSINESS WIRE)--Rogers Corporation (NYSE:ROG) ("Rogers") plans to announce third quarter 2024 results on October, 24, 2024 after market close, which will be followed by a conference call at 5:00 pm ET. The call will be hosted by Colin Gouveia, President ...

Roche receives FDA approval for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY — Oct 18th, 2024

The new VENTANA CLDN18 (43-14A) RxDx Assay helps fulfil an unmet medical need by enabling clinicians to identify patients with gastric or gastroesophageal junction (GEJ) cancer who may benefit from a targeted treatment option. CLDN18.2 is an emerging biomarker in gastric and GEJ cancers a...

Should Weakness in Rogers Corporation's (NYSE:ROG) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? — Oct 21st, 2024

Rogers (NYSE:ROG) has had a rough three months with its share price down 19%. However, the company's fundamentals look pretty decent, and long-term financials are usually aligned with future market price movements. Particularly, we will be paying attention to Rogers' ROE today. Return on...

Survey commissioned by Roche shows that HPV infection, which causes 99% of all cervical cancer cases, remains largely misunderstood by the general public — Oct 8th, 2024

Survey findings from over 8,700 people in 12 countries show that half of those polled have inadequate understanding of HPV, with nearly one-third being unsure or unaware of it altogether.1 Findings also show that significant barriers continue to exist that are preventing women from seekin...

Survey commissioned by Roche shows that HPV infection, which causes 99% of all cervical cancer cases, remains largely misunderstood by the general public — Oct 8th, 2024

Survey findings from over 8,700 people in 12 countries show that half of those polled have inadequate understanding of HPV, with nearly one-third being unsure or unaware of it altogether.1 Findings also show that significant barriers continue to exist that are preventing women from seekin...

Electronic Components Stocks Q2 Results: Benchmarking Allient (NASDAQ:ALNT) — Oct 7th, 2024

Electronic Components Stocks Q2 Results: Benchmarking Allient (NASDAQ:ALNT) The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Allient (NASDAQ:ALNT) and the rest of the...

Rogers Corporation Schedules Third Quarter 2024 Earnings Call for October 24 — Oct 10th, 2024

CHANDLER, Ariz., October 10, 2024--(BUSINESS WIRE)--Rogers Corporation (NYSE:ROG) ("Rogers") plans to announce third quarter 2024 results on October, 24, 2024 after market close, which will be followed by a conference call at 5:00 pm ET. The call will be hosted by Colin Gouveia, President ...

Electronic Components Stocks Q2 Results: Benchmarking Allient (NASDAQ:ALNT) — Oct 7th, 2024

Electronic Components Stocks Q2 Results: Benchmarking Allient (NASDAQ:ALNT) The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Allient (NASDAQ:ALNT) and the rest of the...

Should Weakness in Rogers Corporation's (NYSE:ROG) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? — Oct 21st, 2024

Rogers (NYSE:ROG) has had a rough three months with its share price down 19%. However, the company's fundamentals look pretty decent, and long-term financials are usually aligned with future market price movements. Particularly, we will be paying attention to Rogers' ROE today. Return on...

Should Weakness in Rogers Corporation's (NYSE:ROG) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? — Oct 21st, 2024

Rogers (NYSE:ROG) has had a rough three months with its share price down 19%. However, the company's fundamentals look pretty decent, and long-term financials are usually aligned with future market price movements. Particularly, we will be paying attention to Rogers' ROE today. Return on...

Winners And Losers Of Q2: Rogers (NYSE:ROG) Vs The Rest Of The Electronic Components Stocks — Oct 2nd, 2024

Winners And Losers Of Q2: Rogers (NYSE:ROG) Vs The Rest Of The Electronic Components Stocks As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at electronic components stocks, starti...

Survey commissioned by Roche shows that HPV infection, which causes 99% of all cervical cancer cases, remains largely misunderstood by the general public — Oct 8th, 2024

Survey findings from over 8,700 people in 12 countries show that half of those polled have inadequate understanding of HPV, with nearly one-third being unsure or unaware of it altogether.1 Findings also show that significant barriers continue to exist that are preventing women from seekin...

Roche receives FDA approval for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY — Oct 18th, 2024

The new VENTANA CLDN18 (43-14A) RxDx Assay helps fulfil an unmet medical need by enabling clinicians to identify patients with gastric or gastroesophageal junction (GEJ) cancer who may benefit from a targeted treatment option. CLDN18.2 is an emerging biomarker in gastric and GEJ cancers a...

Rogers Corporation Schedules Third Quarter 2024 Earnings Call for October 24 — Oct 10th, 2024

CHANDLER, Ariz., October 10, 2024--(BUSINESS WIRE)--Rogers Corporation (NYSE:ROG) ("Rogers") plans to announce third quarter 2024 results on October, 24, 2024 after market close, which will be followed by a conference call at 5:00 pm ET. The call will be hosted by Colin Gouveia, President ...

Roche receives FDA approval for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY — Oct 18th, 2024

The new VENTANA CLDN18 (43-14A) RxDx Assay helps fulfil an unmet medical need by enabling clinicians to identify patients with gastric or gastroesophageal junction (GEJ) cancer who may benefit from a targeted treatment option. CLDN18.2 is an emerging biomarker in gastric and GEJ cancers a...

Electronic Components Stocks Q2 Results: Benchmarking Allient (NASDAQ:ALNT) — Oct 7th, 2024

Electronic Components Stocks Q2 Results: Benchmarking Allient (NASDAQ:ALNT) The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Allient (NASDAQ:ALNT) and the rest of the...

Electronic Components Stocks Q2 Results: Benchmarking Allient (NASDAQ:ALNT) — Oct 7th, 2024

Electronic Components Stocks Q2 Results: Benchmarking Allient (NASDAQ:ALNT) The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Allient (NASDAQ:ALNT) and the rest of the...

Survey commissioned by Roche shows that HPV infection, which causes 99% of all cervical cancer cases, remains largely misunderstood by the general public — Oct 8th, 2024

Survey findings from over 8,700 people in 12 countries show that half of those polled have inadequate understanding of HPV, with nearly one-third being unsure or unaware of it altogether.1 Findings also show that significant barriers continue to exist that are preventing women from seekin...

Roche receives FDA approval for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY — Oct 18th, 2024

The new VENTANA CLDN18 (43-14A) RxDx Assay helps fulfil an unmet medical need by enabling clinicians to identify patients with gastric or gastroesophageal junction (GEJ) cancer who may benefit from a targeted treatment option. CLDN18.2 is an emerging biomarker in gastric and GEJ cancers a...

Survey commissioned by Roche shows that HPV infection, which causes 99% of all cervical cancer cases, remains largely misunderstood by the general public — Oct 8th, 2024

Survey findings from over 8,700 people in 12 countries show that half of those polled have inadequate understanding of HPV, with nearly one-third being unsure or unaware of it altogether.1 Findings also show that significant barriers continue to exist that are preventing women from seekin...

Roche receives FDA approval for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY — Oct 18th, 2024

The new VENTANA CLDN18 (43-14A) RxDx Assay helps fulfil an unmet medical need by enabling clinicians to identify patients with gastric or gastroesophageal junction (GEJ) cancer who may benefit from a targeted treatment option. CLDN18.2 is an emerging biomarker in gastric and GEJ cancers a...

Electronic Components Stocks Q2 Results: Benchmarking Allient (NASDAQ:ALNT) — Oct 7th, 2024

Electronic Components Stocks Q2 Results: Benchmarking Allient (NASDAQ:ALNT) The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Allient (NASDAQ:ALNT) and the rest of the...

Rogers Corporation Schedules Third Quarter 2024 Earnings Call for October 24 — Oct 10th, 2024

CHANDLER, Ariz., October 10, 2024--(BUSINESS WIRE)--Rogers Corporation (NYSE:ROG) ("Rogers") plans to announce third quarter 2024 results on October, 24, 2024 after market close, which will be followed by a conference call at 5:00 pm ET. The call will be hosted by Colin Gouveia, President ...

Survey commissioned by Roche shows that HPV infection, which causes 99% of all cervical cancer cases, remains largely misunderstood by the general public — Oct 8th, 2024

Survey findings from over 8,700 people in 12 countries show that half of those polled have inadequate understanding of HPV, with nearly one-third being unsure or unaware of it altogether.1 Findings also show that significant barriers continue to exist that are preventing women from seekin...

Should Weakness in Rogers Corporation's (NYSE:ROG) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? — Oct 21st, 2024

Rogers (NYSE:ROG) has had a rough three months with its share price down 19%. However, the company's fundamentals look pretty decent, and long-term financials are usually aligned with future market price movements. Particularly, we will be paying attention to Rogers' ROE today. Return on...

Roche receives FDA approval for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY — Oct 18th, 2024

The new VENTANA CLDN18 (43-14A) RxDx Assay helps fulfil an unmet medical need by enabling clinicians to identify patients with gastric or gastroesophageal junction (GEJ) cancer who may benefit from a targeted treatment option. CLDN18.2 is an emerging biomarker in gastric and GEJ cancers a...